Companies
Insulet
Medical devicesActon, MassachusettsPODDAbout 5,400 employees
More about Insulet
Medical device company that makes the Omnipod tubeless insulin pump for people with type 1 and type 2 diabetes.
Revenue
$2.7B
Fiscal 2025, up about 31%
Employees
About 5,400
As of December 2025, full-time
Stock
PODD
Nasdaq
Headquarters
Acton, Massachusetts
CEO
Ashley McEvoy
Since April 2025
BrandsOmnipod 5, Omnipod DASH
Current strategyGrowing Omnipod 5 in type 1 and type 2 diabetes and internationally, with Omnipod 6 and a fully closed-loop type 2 system in development and a target of about 20% annual revenue growth through 2028
Recent workforce changesFull-time headcount grew 38% in 2025 to about 5,400
CompetitorsTandem Diabetes Care, Medtronic Diabetes (MiniMed), Beta Bionics
Checked October 11, 2026 · Sources: sec.gov, businesswire.com, medtechdive.com
No source-backed updates for Insulet yet. They appear here when a public report or filing covers the company.
No one has posted about Insulet yet. Be the first to post ›
Follow Insulet in a feed reader, no account needed: RSS feed